The proposal raises how Lithuania’s compulsory health insurance system could change which suppliers may contract to provide compensated medical aids and related products.
A broader contracting route is proposed
Lithuania’s Seimas has given initial approval to amendments proposed by social democrat Saulius Čaplinskas to the Health Insurance Law. The bill would allow the State Health Insurance Fund, known as VLK, to conclude contracts with suppliers for every medical aid included in the Compensated Medical Aids List, regardless of the aid’s classification. At present, such contracts are limited to Class I medical aids and diagnostic tests intended for self-monitoring. The vote was held at the bill’s presentation stage, so the decision supports further legislative consideration rather than establishing the new supply arrangement immediately.
What would change for specialist suppliers
The proposal would also enable specialised suppliers to provide patients with compensated medical aids and special medical-purpose food products on doctors’ prescriptions. The source specifically includes enteral nutrition formulas. In procurement terms, the change concerns the scope of products for which VLK may make supply contracts, as well as the channel through which eligible patients receive them. It is not described as a single tender or as a replacement for pharmacies. Instead, the bill would create a wider basis for contracts with specialised suppliers alongside the existing arrangements, subject to the legislation continuing through the parliamentary process.
Access and supplier conditions are the stated aims
The explanatory case for the amendments is that patients would have better access to compensated medical aids and that suppliers and pharmacies would operate under more equal conditions. That matters for businesses assessing the proposal because the key change is not only the addition of products, but also the possibility of a broader supplier route for items currently handled under narrower contracting rules. The source does not identify particular companies, contract values or award procedures, and it makes no allegation of wrongdoing. It reports an intended change to the legal framework for reimbursement-linked supply, not a finding against an existing provider.
No additional insurance-fund allocation is planned
The bill’s sponsors state that implementing the amendments would not require additional funds from the Compulsory Health Insurance Fund budget, known as PSDF. The proposal therefore combines a wider potential contracting scope with an assertion that the existing fund would cover implementation. That statement describes the expected budget effect of the bill; it does not set out prices, volumes or the financial terms of future supplier contracts. The immediate procedural fact is that 92 Seimas members voted for the amendments at presentation, with no votes against or abstentions reported in the source.
IN NUMBERS
The proposal now moves forward for consideration, with its potential effect centred on VLK’s contracting options and patients’ access to prescribed compensated supplies.
Reported from lrt.lt, 2026-10-13. The Tender Wire is published by Otnox.
